IFP Advisors
MYGN icon

IFP Advisors’s Myriad Genetics MYGN Stock Holding History

IFP Advisors’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.6K Sell
603
-20
-3% -$84 ﹤0.01% 4105
2026
Q2 		$3.56K Buy
623
+56
+10% +$254 ﹤0.01% 3974
2026
Q1 		$2.55K Sell
567
-812
-59% -$4.23K ﹤0.01% 3863
2025
Q4 		$8.48K Buy
1,379
+552
+67% +$4K ﹤0.01% 3151
2025
Q3 		$5.98K Buy
827
+243
+42% +$1.44K ﹤0.01% 3146
2025
Q2 		$3.1K Buy
584
+420
+256% +$2.48K ﹤0.01% 3679
2025
Q1 		$1.46K Buy
164
+153
+1,391% +$1.84K ﹤0.01% 3244
2024
Q4 		$151 Buy
+11
New +$203 ﹤0.01% 3867
2020
Q1 		– Sell
-15
Closed -$317 – 2908
2019
Q4 		$0 Buy
+15
New +$413 ﹤0.01% 3019
2019
Q1 		– Sell
-225
Closed -$6K – 3029
2018
Q4 		$6K Sell
225
-1,869
-89% -$67.2K ﹤0.01% 2763
2018
Q3 		$96K Buy
2,094
+135
+7% +$6K ﹤0.01% 1494
2018
Q2 		$73K Buy
1,959
+725
+59% +$24.5K ﹤0.01% 1685
2018
Q1 		$42K Hold
1,234
– – ﹤0.01% 1920
2017
Q4 		$42K Buy
1,234
+685
+125% +$23.1K ﹤0.01% 1941
2017
Q3 		$20K Buy
549
+350
+176% +$10K ﹤0.01% 2586
2017
Q2 		$5K Sell
199
-41
-17% -$870 ﹤0.01% 3414
2017
Q1 		$5K Hold
240
– – ﹤0.01% 3308
2016
Q4 		$4K Sell
240
-630
-72% -$11.4K ﹤0.01% 3409
2016
Q3 		$18K Hold
870
– – ﹤0.01% 2469
2016
Q2 		$27K Buy
+870
New +$30.2K ﹤0.01% 2155
2016
Q1 		– Sell
-800
Closed -$35K – 3025
2015
Q4 		$35K Buy
+800
New +$33.8K ﹤0.01% 1821

Other funds holding MYGN

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return

IFP Advisors's MYGN Position: Q3 2026 in Review

IFP Advisors reduced its Myriad Genetics (MYGN) stake by 3.2% in Q3 2026, selling an estimated $84 and leaving 603 shares worth $2.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4105.

IFP Advisors first reported a position in MYGN in Q4 2015 and has held it in 21 quarters since. The position peaked at $96K in Q3 2018. 126 funds tracked by Wall St. Rank hold MYGN as of Q3 2026.

  • IFP Advisors held 603 shares of Myriad Genetics worth $2.6K as of Q3 2026.
  • IFP Advisors sold 20 Myriad Genetics shares in Q3 2026, an estimated $84.
  • Myriad Genetics made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #4105 holding.
  • IFP Advisors first reported a position in Myriad Genetics in Q4 2015 and has held it in 21 quarters since.
  • IFP Advisors's Myriad Genetics position peaked at $96K in Q3 2018.
  • 126 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2026.

Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.